These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases. Disse B. Novartis Found Symp; 2002 Jul; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499 [Abstract] [Full Text] [Related]
5. Mucus-controlling agents: past and present. King M, Rubin BK. Respir Care Clin N Am; 1999 Dec; 5(4):575-94. PubMed ID: 10565882 [Abstract] [Full Text] [Related]
6. [Novel approach to respiratory pharmacology--pharmacological basis of cough, sputum and airway clearance]. Miyata T. Yakugaku Zasshi; 2003 Dec; 123(12):987-1006. PubMed ID: 14689863 [Abstract] [Full Text] [Related]
8. Evaluating the efficacy of mucoactive aerosol therapy. Fuloria M, Rubin BK. Respir Care; 2000 Jul; 45(7):868-73. PubMed ID: 10926385 [Abstract] [Full Text] [Related]
9. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature. Boogaard R, de Jongste JC, Merkus PJ. Pediatr Pulmonol; 2007 Nov; 42(11):989-1001. PubMed ID: 17902149 [Abstract] [Full Text] [Related]
10. Rheological profile of nesosteine: a new mucoactive agent. Braga PC, Beghi G, Castelli C, Grasselli G, Ornaghi A, Rampoldi C, Zheng Y, Allegra L. Int J Clin Pharmacol Res; 1989 Nov; 9(1):77-83. PubMed ID: 2707929 [Abstract] [Full Text] [Related]
11. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action]. Kupczyk M, Kuna P. Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600 [Abstract] [Full Text] [Related]
12. Inhaled adrenergics and anticholinergics in obstructive lung disease: do they enhance mucociliary clearance? Restrepo RD. Respir Care; 2007 Sep; 52(9):1159-73; discussion 1173-5. PubMed ID: 17716384 [Abstract] [Full Text] [Related]
13. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care? Bilton D, Stanford G. Curr Opin Pulm Med; 2014 Nov; 20(6):601-6. PubMed ID: 25221855 [Abstract] [Full Text] [Related]
17. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties]. Kupczyk M, Kuna P. Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601 [Abstract] [Full Text] [Related]